O6-alkylguanine-DNA alkyltransferase DNA repair in mycobacteria: Pathogenic and non-pathogenic species differ

Tuberculosis

Volumn 82, Issue 2-3, 2002, Pages 45-53

  Wiid, I ^a   Grundlingh, R ^a   Bourn, W ^a   Bradley, G ^a   Harington, A ^a   Hoal Van Helden, E G ^a   Van Helden, P ^a  

^a UNIVERSITY OF STELLENBOSCH   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

6 O ALKYLGUANINE DNA ALKYLTRANSFERASE; BACTERIAL DNA; BCG VACCINE; ISONIAZID; MUTAGENIC AGENT; STREPTOZOCIN; TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENOME; BACTERIAL GROWTH; BACTERIAL SURVIVAL; CULTURE MEDIUM; DNA REPAIR; ENZYME ACTIVITY; KNOCKOUT GENE; MACROPHAGE; MINIMUM INHIBITORY CONCENTRATION; MUTAGENESIS; MYCOBACTERIUM; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; SOUTHERN BLOTTING; SPECIES DIFFERENCE;

MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS;

EID: 0036395994     PISSN: 14729792     EISSN: None     Source Type: Journal    
DOI: 10.1054/tube.2002.0316     Document Type: Article

References (40)

1. Jackson P E, Hall C N, O'Connor P J, Cooper D P, Margison G P, Povey A C. Low O6-alkylguanine DNA-alkyltransferase activity in normal colorectal tissue is associated with colorectal tumours containing a GC→AT transition in the K-ras oncogene. Carcinogenesis 1997; 18: 1299-1302.
2. Vidal A, Abril N, Pueyo C. The influence of DNA repair by Ogt alkyltransferase on the distribution of alkylnitrosourea-induced mutations in Escherichia coli. Environ Mol Mutagen 1997; 29: 180-188.
3. Luque-Romero F L, Iannone R, Inga A, Fronza G, Pueyo C. Mutational specificity of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in Escherichia coli: comparison of in vivo with in vitro exposure of the supF gene. Environ Mol Mutagen 1997; 30: 65-71.
4. Victor T C, Jordaan A M, van Rie A et al. Detection of mutations in drug resistance genes of Mycobacterium tuberculosis by a dot-blot hybridization strategy. Tuber Lung Dis 1999; 79: 343-348.
5. Sintchenko V, Jelfs P J, Chew W K, Gilbert G L. Mycobacterium tuberculosis rpoB gene DNA sequencing: implications for detection of rifamycin resistance. J Atimicrob Chemother 1999; 44: 294-295.
6. Sintchenko V, Chew W K, Jelfs P J, Gilbert G L. Mutations in rpoB gene and rifabutin susceptibility of multidrug-resistant Mycobacterium tuberculosis strains isolated in Australia. Pathology 1999; 31: 257-260.
7. Scarpellini P, Braglia Carrera P et al. Detection of rifampin resistance in Mycobacterium tuberculosis by double gradient-denaturing gradient gel electrophoresis. Antimicrob Agents Chemother 1999; 43: 2550-2554.
8. Goyal M, Shaw R J, Banerkjee D K, Coker R J, Robertson B D, Young D B. Rapid detection of multidrug-resistant tuberculosis. Eur Respir J 1997; 10: 1120-1124.
9. Lindahl T, Sedgwick B, Sekiguchi M, Nakabeppu Y. Regulation and expression of the adaptive response to alkylating agents. Annu Rev Biochem 1998; 57: 133-157.
10. Abril N, Lugue-Romero F L, Prieto-Alamo M J, Rafferty J A, Margison G P, Pueyo C. Bacterial and mammalian DNA alkyltransferases sensitize Escherichia coli to the lethal and mutagenic effects of dibromoalkanes. Carcinogenesis 1997; 18: 1883-1888.
11. Vaughan P, Sedgwick B, Hall J, Cannon J, Lindahl T. Environmental mutagens that induce the adaptive response to alkylating agents in Escherichia coli. Carcinogenesis 1991; 12: 263-268.
12. Mizrahi V, Andersen S J. DNA repair in Mycobacterium tuberculosis. What have we learnt from the genome sequence? Mol Microbiol 1998; 29: 1331-1339.
13. Sambrook J, Fritsch E F, Maniatis T. Molecular Cloning. A laboratory manual. Cold Spring Harbour Laboratory Press. 1989.
14. Wilson B D, Strauss M, Stickells B J, Hoal-Van Helden E G, van Helden P. An assay for O6-alkylguanine-DNA alkyltransferase based on restriction endonuclease inhibition and magnetic bead separation of products. Carcinogenesis 1994; 15: 2143-2148.
15. McAdam R A, Weisbroad T R, Martin J et al. In vivo growth characteristics of leucine and methionine auxotrophic mutants of Mycobacterium bovis BCG generated by transposon mutagenesis. Infect Immun 1995; 63: 1004-1012.
16. van Zyl J M, Basson K, Kriegler A, van der Walt B J. Cytotoxicity of myeloperoxidase-activated catechols: oxidative injury to the red blood cell. Toxicology 2001; 68(1): 37-49.
17. Elder R H, Tumelty J, Douglas K T, Margison G P, Rafferty J A. C-terminally truncated human O6-alkylguanine-DNA alkyltransferase retains activity. Biochem J 1992; 285 (Pt 3): 707-709.
18. Wiid I J, Werely C, Beyers N, Donald P, van Helden P D. Oligonucleotide (GTG) as a marker for Mycobacterium tuberculosis strain identification. J Clin Microbiol 1994; 32: 1318-1321.
19. Warren R, Richardson M, Victor T, Sampson S, Beyers N, van Helden P. DNA fingerprinting and molecular epidemiology of tuberculosis: use and interpretation in an epidemic setting. Electrophoresis 1999; 20: 1807-1812.
20. Bourn W R, Harington A, Wiid I, van Helden P D. Mycobacterium tuberculosis 3-methyladenine glycosidase and O6-methylguanine methyltransferase genes. Genbank Accession U65786, 1996.
21. Hoal-van Helden E G, Hon D, Lewis L A, Beyers N, van Helden P D. Mycobacterial growth in human macrophages: Variation according to donor, inoculum and bacterial strain. Cell Biol Int 2001; 25: 77-81.
22. Miller M A, Thibert L, Desjardins F, Siddiqi S H, Dascal A. Testing of susceptibility of Mycobacterium tuberculosis to pyrazinamide: comparison of Bactec method with pyrazinamidase assay. J Clin Microbiol 1995; 33: 2468-2470.
23. Siddiqi S H. 460TB system. Product and procedure manual. Becton Dickinson and Company, Maryland, USA, 1995.
24. Emerit J, Beaumont C, Trivin F. Iron metabolism, free radicals, and oxidative injury. Biomed Pharmacother 2001; 55: 333-339.
25. Andersson A K, Sandler S. Melatonin protects against streptozotocin, but not interleukin-1beta-induced damage of rodent pancreatic beta-cells. J Pineal Res 2001; 30: 157-165.
26. Friedberg E C, Walker G C, Siede W. DNA repair and mutagenesis. ASM press, Washington, 1995; ISBN 1-55581-088-8.
27. Brosch R, Gordon S V, Pym A, Eiglmeier K, Garnier T, Cole S T. Comparative genomics of the mycobacteria. Int J Med Microbiol 2000; 290: 143-152.
28. Brosch R, Gordon S V, Eiglmeier K, Garnier T, Coles S T. Comparative genomics of the leprosy and tubercle bacilli. Res Microbiol 2000; 151: 135-142.
29. Suzuki K, Lee W J, Hashimoto T et al. Recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF) or tumour necrosis factor-alpha (TNF-alpha) activate human alveolar macrophages to inhibit growth of Mycobacterium avium complex. Clin Exp Immunol 1994; 98: 169-173.
30. Cole S T, Brosch R, Parkhill J et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 1998; 393: 537-544.
31. Newton G L, Av-Gay Y, Fahey R C. A novel mycothiol-dependent detoxification pathway in mycobacteria involving mycothiol S-conjugate amidase. Biochemistry 2000; 39: 10739-10746.
32. Vaughan P, Sedgwick B. A weak adaptive response to alkylation damage in Salmonella typhimurium. J Bacteriol 1991; 173: 3656-3662.
33. Sedgwick B, Vaughan P. Widespread adaptive response against environmental methylating agents in microorganisms. Mutat Res 1991; 250: 211-221.
34. Suzuki M, Matsui K, Yamada M, Kasai H, Sofuni T, Nohmi T. Construction of mutants of Salmonella typhimurium deficient in 8-hydroxyguanine DNA glycosylase and their sensitivities to oxidative mutagens and nitro compounds. Mutat Res 1997; 393: 233-246.
35. Sreevatsan S, Pan X, Stockbauer K E et al. Restricted structural gene polymorphism in the Mycobacterium tuberculosis comolex indicates evolutionarily recent global dissemination. Proc Natl Acad Sci U S A 1997; 94: 9869-9874.
36. Blanco M, Martinez A, Urios A, Herrera G, O'Connor J E. Detection of oxidative mutagenesis by isoniazid and other hydrazine derivatives in Escherichia coli WP2 tester strain IC203, deficient in OxyR: strong protective effects of rat liver S9. Mutat Res 1998; 417: 39-46.
37. Sedgewick B. Oxidation of methylhydrazines to mutagenic methylating derivatives and inducers of the adaptive response of Escherichia coli to alkylation damage. Cancer Res 1992; 52: 3693-3697.
38. Albano E, Tomasi A. Spin trapping of free radical intermediates produced during the metabolism of isoniazid and iproniazid in isolated hepatocytes. Biochem Pharmacol 1987; 36: 2913-2920.
39. Ito K, Yamamoto K, Kawanishi S. Manganese-mediated oxidative damage of cellular and isolated DNA by isoniazid and related hydrazines: non-Fenton-type hydroxyl radical formation. Biochemistry 1992; 31: 11606-11613.
40. Westphal J F, Vetter D, Brogard J M. Hepatic side-effects of antibiotics. J Antimicrob Chemother 1994; 33: 387-401.